Therapeutic groups

Gross spend in millions

  Therapeutic group Main indication 2020 2021 2022 2023

1

Immunosuppressants

Autoimmune conditions, arthritis, transplant and biologics for cancer

$280.3

$297.3

$326.5

$311.3

2

Chemotherapeutic Agents

Cancer

$103.9

$138.7

$150.0

$154.2

3

Diabetes

Diabetes

$75.8

$91.8

$123.7

$146.6

4

Vaccinations

Vaccine preventable diseases

$117.4

$115.9

$111.9

$128.8

5

Antithrombotic Agents

Stopping blood clots

$76.0

$86.2

$96.6

$103.6

6

Inhaled Long-acting Beta-adrenoceptor Agonists

Respiratory conditions

$63.4

$67.4

$75.6

$73.4

7

Antifibrinolytics, Haemostatics and Local Sclerosants

Haemophilia

$51.3

$55.6

$58.9

$61.3

8

Multiple Sclerosis Treatments

Multiple sclerosis

$33.4

$39.4

$44.1

$49.3

9

Antivirals

Hepatitis C

$135.1

$62.6

$39.91

$48.51

10

Mucolytics

Respiratory system and allergies

$2.4

$7.8

$14.2

$44.7

11

Antipsychotics

Mental health

$35.6

$37.3

$38.6

$40.7

12

Endocrine Therapy

HRT

$41.3

$47.9

$43.8

$40.7

13

Agents Affecting the Renin-Angiotensin System

Blood pressure, heart failure, kidney failure, and effects of diabetes

$15.5

$22.1

$31.7

$38.7

14

Anticholinergic Agents

Respiratory conditions

$28.8

$31.4

$33.3

$34.6

15

Antiretrovirals

HIV/AIDS

$24

$26.6

$28.2

$31.8

16

Diabetes Management

Blood glucose monitors and strips

$25.1

$26.7

$29.4

$31.6

17

Antiepilepsy Drugs

Epilepsy

$26.8

$27.2

$29.3

$31.2

18

Analgesics

Pain relief

$17.4

$27.6

$26.8

$26.8

19

Oral and Enteral Feeds

Special food

$17.9

$20.2

$23.5

$26.0

20

Stimulants/ADHD Treatments

ADHD and narcolepsy

$11.0

$11.4

$13.4

$16.8

 

 

Totals

$1,182.4

$1,241.1

$1,339.4

$1,440.6

The data above excludes hospital purchases.

List order has been determined by top spend in the financial year 2021/22.

The gross spend is shown in millions NZD, is exclusive of GST, and prior to the application of rebates and discounts.